Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3778 3782 3785 3791
This examiner grants 66% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18786021 | A MASK WITH A VALVE | Non-Final OA | DCSTAR INC |
| 18416124 | PATIENT INTERFACE CUSHION | Final Rejection | DCSTAR INC |
| 18515499 | FRAME ASSEMBLY DIRECTLY CONNECTED TO A FRAME AND A SHORT TUBE | Final Rejection | DCSTAR INC. |
| 17806252 | INHALER DEVICES, MEDICATION FORMULATIONS USED THEREWITH AND METHODS OF MANUFACTURE | Non-Final OA | Genentech, Inc. |
| 18347159 | APPARATUS FOR SUPPLYING GASES TO A PATIENT | Final Rejection | FISHER & PAYKEL HEALTHCARE LIMITED |
| 18342280 | BREATHABLE MASK | Non-Final OA | QBAS Co., Ltd. |
| 18341403 | BREATHABLE MASK FOR SNORKELING | Non-Final OA | QBAS Co., Ltd. |
| 18441715 | ORO-NASAL PATIENT INTERFACE | Non-Final OA | RESMED PTY LTD |
| 17948511 | TEXTILE MASK SYSTEMS | Final Rejection | ResMed Pty Ltd |
| 17507931 | NOSE CONE VENT DESIGN FOR INHALATION DEVICE | Final Rejection | Brady Worldwide, Inc. |
| 18277527 | MEDICO-SURGICAL TUBES | Non-Final OA | SMITHS MEDICAL INTERNATIONAL LIMITED |
| 18448570 | Dry Powder Medicament Inhaler | Final Rejection | NORTON (WATERFORD) LIMITED |
| 17794875 | AIR-JET DRY POWER INHALER FOR RAPID DELIVERY OF PHARMACEUTICAL AEROSOLS TO INFANTS | Non-Final OA | Virginia Commonwealth University |
| 17930531 | USE OF CANNABINOIDS IN THERAPY AND WELL-BEING APPARATUSES | Final Rejection | JK-HOLDING GMBH |
| 18419891 | RESPIRATORY THERAPY KITS | Final Rejection | YASI'S LLC |
| 18006487 | DOSE COUNTER ASSEMBLIES FOR MEDICAMENT DISPENSERS | Final Rejection | LUPIN INC. |
| 17890383 | Positive Airway Pressure Mask with Reduced Airflow During Exhalation | Non-Final OA | Encite LLC |
| 17889141 | METHODS AND APPARATUSES FOR DELIVERY OF AN AGENT TO THE LUNGS AND NASAL PASSAGES | Non-Final OA | Inhalon Biopharma, Inc. |
| 17299019 | MOUTHPIECE AND NEBULIZER HAVING A MOUTHPIECE | Non-Final OA | PARI Pharma GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy